Cited by 618Single-cell and spatial transcriptomicsCancer Genomics and DiagnosticsCancer Cells and Metastasis

Tumour heterogeneity and metastasis at single-cell resolution

Open access
Lawson, Devon A., Kessenbrock, Kai, Davis, Ryan T., Pervolarakis, Nicholas, Werb, Zena·2018·Nature Cell Biology

Abstract

Tumours comprise a heterogeneous collection of cells with distinct genetic and phenotypic properties that can differentially promote progression, metastasis and drug resistance. Emerging single-cell technologies provide a new opportunity to profile individual cells within tumours and investigate what roles they play in these processes. This Review discusses key technological considerations for single-cell studies in cancer, new findings using single-cell technologies and critical open questions for future applications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41556-018-0236-7

Cites

157 of 158 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Single-cell methods applied to cancer cells have described heterogeneity in transcriptomics, epigenomics, metabolomics, and proteomics.

    “Indeed, single-cell methods applied to cancer cells have described heterogeneity in terms of transcriptomics, epigenomics, metabolomics, and proteomics,5,6”

    From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [6]

    The review describes transcriptomic, epigenetic and proteomic differences between cancer cells (opening section, page unavailable), and its diagnostics section reports heterogeneity detected by single-cell RNA-seq and mass cytometry. It does not describe single-cell metabolomic heterogeneity in cancer cells; searches for “metabolomics” and “metabolite” found no supporting passage. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Evidence points to a substantial level of metabolic heterogeneity even in aggressive cancers.

    “evidence points to a substantial level of metabolic heterogeneity even in aggressive cancers”

    From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [6]

    The Abstract describes pervasive heterogeneity in human cancers, supporting the general point. The section ‘Non-genetic heterogeneity and cellular differentiation’ mentions differences in metabolic state among cells in normal tissues, but does not establish substantial metabolic heterogeneity in aggressive cancers. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Desynchronized dynamics would ration resources evenly, while maintaining a relatively normal bulk metabolic rate, as shown in primary tumors.

    “Desynchronized dynamics would ration resources evenly, while maintaining a relatively “normal” bulk metabolic rate, as shown in primary tumors.”

    From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [6]

    The Non-genetic heterogeneity and cellular differentiation section (page unavailable) mentions differences in cellular metabolic state, but does not discuss desynchronized dynamics, even resource allocation, or a normal bulk metabolic rate in primary tumours. Searches for those terms and related concepts found no passage addressing the attributed claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [53]Miron A PIK3CA mutations in in situ and invasive breastcarcinomas. Cancer Res. 70, 5674– 5678 (2010). 20551053 PMC2905503
  2. [111]Tirosh I Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189– 196 (2016). 27124452 PMC4944528
  3. [115]Klein AM Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187– 1201 (2015). 26000487 PMC4441768
  4. [122]Cao J Comprehensive single-cell transcriptional profiling of a multicellular organism. Science 357, 661– 667 (2017). 28818938 PMC5894354

Cited by

Sorted by citations

Authors
Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N., & Werb, Z.
Affiliations
  • University of California, Irvine (US)
  • University of California, San Francisco (US)
Corresponding author
  • Lawson, Devon A.
  • Kessenbrock, Kai
Venue
Nature Cell Biology
Published
2018-11-26
Volume
20
Issue
12
Pages
1349-1360
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W2900850487
Cited by
606
References
157
Citations by year
2026: 51 · 2025: 78 · 2024: 89 · 2023: 74 · 2022: 90 · 2021: 98 · 2020: 76 · 2019: 48 · 2018: 1 · 2015: 1
FWCI
5.55
Type
journal article
Language
en
Open access
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Cancer Institute (R00CA181490, U01CA199315, K22CA190511, U54CA217378, T32CA009054)
  • National Institute of Biomedical Imaging and Bioengineering (T32EB009418)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
tumor heterogeneity, metastasis, single-cell technologies, single-cell profiling, tumor progression, drug resistance, tumor cell subpopulations
MeSH terms
Humans, Neoplastic Cells, Circulating, Neoplasm Metastasis, Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Genetic Heterogeneity, Single-Cell Analysis, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review